vimarsana.com
Home
Live Updates
GeneQuantum and InxMed have reached a technology licensing c
GeneQuantum and InxMed have reached a technology licensing c
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development
/PRNewswire/ -- On July 14, 2023, GeneQuantum, a leading pioneer committed to innovative bioconjugation technology, and InxMed, a clinical-stage biotechnology...
Related Keywords
Suzhou ,
Jiangsu ,
China ,
Beijing ,
Nanjing ,
Canada ,
Gang Qin ,
Xizang ,
Shanghai ,
United States ,
Australia ,
Zaiqi Wang ,
Drug Administration ,
China National Medical Products Administration ,
Focal Adhesion Kinase ,
Fast Track Designation ,
Breakthrough Therapy Designation ,
China National Medical Products ,
Genequantum Healthcare ,